JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.30 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $597,000 | -22.4% | 31,662 | +23.5% | 0.00% | 0.0% |
| Q3 2016 | $769,000 | -21.0% | 25,635 | +1.3% | 0.00% | 0.0% |
| Q2 2016 | $973,000 | +446.6% | 25,315 | +440.3% | 0.00% | – |
| Q1 2016 | $178,000 | -33.3% | 4,685 | -22.9% | 0.00% | – |
| Q4 2015 | $267,000 | +11.7% | 6,076 | +3.3% | 0.00% | – |
| Q3 2015 | $239,000 | -32.5% | 5,883 | -11.3% | 0.00% | – |
| Q2 2015 | $354,000 | +91.4% | 6,630 | +117.6% | 0.00% | – |
| Q1 2015 | $185,000 | -59.3% | 3,047 | -65.0% | 0.00% | -100.0% |
| Q4 2014 | $454,000 | – | 8,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,864,174 | $85,211,000 | 94.86% |
| Crestline Management, LP | 7,631,631 | $348,841,000 | 35.74% |
| Omega Fund Management, LLC | 753,564 | $34,445,000 | 24.90% |
| DDD Partners, LLC | 191,458 | $8,752,000 | 3.40% |
| SIB LLC | 100,000 | $4,571,000 | 3.28% |
| PECONIC PARTNERS LLC | 433,587 | $19,819,000 | 2.85% |
| Cormorant Asset Management, LP | 550,000 | $25,141,000 | 2.63% |
| ARK Investment Management | 682,495 | $31,197,000 | 2.48% |
| BB BIOTECH AG | 1,925,000 | $87,992,000 | 2.48% |
| Clarius Group, LLC | 120,988 | $5,530,000 | 2.47% |